Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2875 of 3284 entries
View as:

A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02224157 Org: User:
Start: 11/28/14 End: 08/16/17 Due: 08/16/18

Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia

Phase: N/A Priority: Normal
NCT ID: NCT06759519 Org: User:
Start: 04/29/24 End: 09/30/25 Due: 09/30/26

Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant Users

Phase: N/A Priority: Normal
NCT ID: NCT00902772 Org: User:
Start: 05/31/09 End: 09/30/09 Due: 09/30/10

Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02157935 Org: User:
Start: 06/27/14 End: 02/08/16 Due: 02/08/17

AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02151981 Org: User:
Start: 08/04/14 End: 12/15/23 Due: 12/15/24

A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03843060 Org: User:
Start: 02/22/19 End: 04/01/19 Due: 04/01/20

An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium

Phase: N/A Priority: Normal
NCT ID: NCT00428701 Org: User:
Start: 10/31/06 End: 11/30/06 Due: 11/30/07

Study in Taiwanese Subjects Identified as CYP2C19 Poor and Extensive Metabolizers Receiving Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT00766025 Org: User:
Start: 09/30/08 End: 02/28/09 Due: 02/28/10

Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)

Phase: N/A Priority: Normal
NCT ID: NCT00242320 Org: User:
Start: 08/31/05 End: 08/31/07 Due: 08/31/08

A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China

Phase: N/A Priority: Normal
NCT ID: NCT02600221 Org: User:
Start: 10/22/15 End: 10/24/16 Due: 10/24/17

Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient

Phase: N/A Priority: Normal
NCT ID: NCT01085474 Org: User:
Start: 04/30/10 End: 07/31/11 Due: 07/31/12

Quetiapine Efficacy in Bipolar Depression Study

Phase: N/A Priority: Normal
NCT ID: NCT00523601 Org: User:
Start: 06/30/07 End: 12/31/07 Due: 12/31/08

Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01843062 Org: User:
Start: 08/27/13 End: 03/06/19 Due: 03/06/20

Retrospective Study on Characteristics and Outcomes in Hospitalised Patients Treated With Ondexxya

Phase: N/A Priority: Normal
NCT ID: NCT05898412 Org: User:
Start: 10/06/23 End: 05/31/25 Due: 05/31/26

Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02229383 Org: User:
Start: 09/06/14 End: 08/29/16 Due: 08/29/17

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

Phase: N/A Priority: Normal
NCT ID: NCT06595238 Org: User:
Start: 10/01/24 End: 12/08/25 Due: 12/08/26

A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02777827 Org: User:
Start: 06/21/16 End: 11/29/16 Due: 11/29/17

AZD9773 Dose Escalation Study

Phase: N/A Priority: Normal
NCT ID: NCT00615017 Org: User:
Start: 01/31/08 End: 07/31/09 Due: 07/31/10

AZD 2066 Single Dose Formulation and Food Effect Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00690404 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT00653588 Org: User:
Start: 04/30/03 End: 09/30/04 Due: 09/30/05

A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women

Phase: N/A Priority: Normal
NCT ID: NCT00228475 Org: User:
Start: 09/30/04 End: 10/31/05 Due: 10/31/06

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06467357 Org: User:
Start: 08/12/24 End: 05/16/29 Due: 05/16/30

Pharmacokinetic and Safety Study of Subcutaneous and Intravenous Anifrolumab Delivered in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06662123 Org: User:
Start: 10/21/24 End: 01/10/25 Due: 01/10/26

A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06942923 Org: User:
Start: 04/22/25 End: 08/07/25 Due: 08/07/26

Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)

Phase: N/A Priority: Normal
NCT ID: NCT00634400 Org: User:
Start: 03/31/99 End: 05/31/03 Due: 05/31/04